Hyperosmolality suppresses but TGFβ1 increases MMP9 in human peritoneal mesothelial cells  by Rougier, Jean-Philippe et al.
Kidney International, Vol. 51(1997), pp. 337—347
Hyperosmolality suppresses but TGF1 increases MMP9 in
human peritoneal mesothelial cells
JEAN-PHILIPPE ROUGIER, PHILIPPE MOULLIER, REMI PIEDAGNEL, and PIERRE M. RoNco, with the
technical assistance of SOPHIE GUIA
Institut National de Ia Sante et de la Recherche Médicale, Unit 64, and Department of Nephrology, Hopital Tenon, Assistance Publique-Hôpitau.x de
Paris, Paris; Institut Pasteur, Paris; and Gambro Sit., Colombes, France
Hyperosmolality suppresses but TGF1 increases MMP9 in human
peritoneal mesothelial cells. Peritoneal mesothelial cells are directly
exposed to hyperosmolar dialysates which may enhance extracellular
matrix accumulation and hence compromise ultrafiltration. Because these
cells are laid on a type IV collagen containing basement membrane, we
examined the pattern of type IV collagenases produced by cultured human
mesothelial cells and their regulation by hyperosmolality and TGF/31. A
cell line (HMrSV5) exhibiting major features of normal peritoneal
mesothelial cells was derived from a primaly culture retrovirally trans-
duced with SV4O large-T antigen. Zymography and Western blot analysis
showed that: (I) human peritoneal mesothelial cells produced and ex-
creted MMP2 and MMP9 and their inhibitors TIMPI and TIMP2; (ii)
hyperosmolality drastically reduced the expression of MMP9 irrespective
of the osmolyte used in a time- and concentration-dependent manner; (iii)
TGFf31 unexpectedly increased MMP9 activity and protein in exponen-
tially growing cells and could restore MMP9 activity suppressed by
hyperosmolality in confluent cultures. To exclude a specific effect of SV4O
large-T antigen on matrix metalloproteinases production and regulation,
these results were confirmed in primary cultures derived from visceral
peritoneal samples from different donors. Therefore, the hyperosmolality
of dialysates may favor an accumulation of type IV collagen and thicken-
ing of peritoneal basement membrane, while TGFJ31 released during
infections may induce the degradation of type IV collagen and its
replacement by interstitial collagens.
Peritoneal dialysis is based on the selective exchanges that
occur across the large surface area of the mesothelium between
the peritoneal cavity and the circulatory system. Its long-term
efficacy is compromised by progressive ultrafiltration failure. This
complication is commonly associated with a thickening of the
peritoncal basement membrane and with submesothelial perito-
neal fibrosis [1], which may result from an increased synthesis of
extraccilular matrix components and/or from a decreased protein-
ase activity.
A large body of evidence suggests that mesothelial cells could
play a role in submesothelial matrix remodeling. They produce a
variety of extracellular matrix components including fibronectin,
laminin, and type I, type 111, and type IV collagens [2, 31. They are
directly involved in fibrinolytic pathways [4, 5] which may activate
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the proenzymatic forms of matrix metalloproteinases (MMP) [6].
They also release two MMPs, MMP2 and MMP9, and their tissue
inhibitors (TIMP5) [71. MMP2 and MMP9 are of special interest.
First, they degrade type IV collagen which is the collagen of
basement membranes [8, 9]. Second, they are regulated during
normal or pathological remodeling processes [8, 10]. TGFJ3 plays
a pivotal role among the cytokines and growth factors which
induce or inhibit the synthesis of MMPs and TIMPs. It usually
decreases proteinase activities while it increases proteinase inhib-
itor synthesis and collagen production, thus favoring fibrogenesis
[11]. However, in a few models, TGFJ3 displays a stimulating effect
on MMP2 or MMP9 activity [12—15].
During peritoneal dialysis, mesothelial cells are directly ex-
posed to chronic aggression by acidic and hyperosmotic peritoneal
dialysates and to repeated insults by infection, due to their
superficial localization along the peritoneal cavity. In vitro toxicity
of dialysates on mesothelial cells is mainly osmolality-mediated
[16, 17] but the effects of hyperosmolality on mesothelial functions
have not been investigated yet.
We hypothesized that part of the alterations of the peritoneal
barrier observed in patients on peritoneal dialysis were due to the
fibrogenetic effects of dialysis fluids whose osmolality can reach
500 mOsm/kg and to TGFI3 that is most likely released in the
peritoneal cavity during peritonitis. This hypothesis was tested
with a newly established human peritoneal mesothelial cell line
retrovirally immortalized with the SV4O large-T antigen (Ag). The
results suggest that hyperosmolar dialysates may enhance base-
ment membrane thickening while TGFf31 may favor degradation
of basement membrane type IV collagen in regenerating mesothe-
hum after infection.
Methods
Primary cultures of peritoneal mesothelial cells
Isolation of peritoneal mesothclial cells was performed essen-
tially as already described [18]. Briefly, 10 cm2 samples of surgical
waste omentum were obtained from 18 patients undergoing
abdominal surgery with omentectomy. After washing in sterile
PBS (pH 7.4), they were incubated with 0.25% trypsin for 25
minutes at 37°C with continuous agitation. Digested pieces of
omentum were then discarded and the cell suspension was
centrifuged at 580 g for five minutes. The cell pellet was washed
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once in Dulbecco's modified Eagle medium (DMEM) supple-
mented with 2 m'vi glutamine and 10% heat inactivated fetal calf
serum (complete medium), and seeded in type I collagen-coated
tissue culture dishes. After overnight incubation (37°C, 5% C02,
humidified incubator) non-adherent cells were removed and the
medium was changed every other day until confluence. Under
these conditions, cells could be subcultured for 4 to 5 passages but
only primary cultures were used for experiments.
Establishment of a human peritoneal mesothelial cell line
We used an amphotropic recombinant retrovirus that encodes
SV4O large-T Ag under the control of the Moloney virus long
terminal repeat (LTR), and resistance to the antibiotic G418
under the control of the SV4O early promoter. The retroviral
construct was derived by inserting SV4O large-T Ag encoding
DNA fragment into the unique BamHI site of the retroviral
pZipNeoSV(X)1 shuttle vector [19]. The viral supernatant was
obtained from a stable "I'2 producer line [20]. To transduce
human cells, virus from cloned 1112 producers of pZipNeoSV(X)1
was used to infect the 'P-CRIP packaging cell line that expresses
the amphotropic envelop [21]. After 48 hours, infected cells were
grown in the presence of 1 mg/ml G418 for two weeks. Clones of
G418-resistant '11-CRIP were isolated and tested for their ability
to transform human primary skin fibroblasts in vitro. We selected
one clone, CRIP-SV4O, with titers of I x 106 G418 resistant
colonies per ml. The supernatant was tested for the presence of
replicative competent retroviruses using the 3T3 BAG test [22].
Despite repetitive assays, none was detected.
Primary cultured human peritoneal mesothelial cells exponen-
tially growing in 100-mm diameter Petri dishes were infected at
37°C for two hours with 2 ml retrovirus containing filtered
supernatant in the presence of 8 jig/mI of polybrene, after which
8 ml of complete medium were added. Forty-eight hours after
infection, the cells were passaged and the G418 resistant cells
were isolated by selection in complete medium containing G418
(1 mg/mI).
After 10 to 15 days, colonies of transduced mesothelial cells
were identified by phase contrast microscopy. Single colonies were
isolated by trypsinization in a plastic ring sealed around the
colonies by means of silicon grease. They were subsequently
expanded in G418 containing complete medium. Clones were
further subcultured in type I collagen-coated dishes in complete
medium. All experiments on immortalized mesothelial cells were
performed on the same clone between passages 5 and 10.
Morphological studies
Immunolluorescence was performed on mesothelial cell mono-
layers grown in 35-mm diameter collagen-coated Petri dishes.
Cells were fixed for 10 minutes in 4% paraformaldehyde and
permeahilized with 0.2% Triton X-100 for 10 minutes at room
temperature. Cells were then washed in PBS and incubated with
the first nionoclonal or polyclonal antibody at the appropriate
dilution for 20 minutes at room temperature. Controls were
obtained by substituting appropriate irrelevant antibodies for the
first antibody. After three washes, cells were incubated with the
appropriate FITC-conjugated goat anti-mouse or anti-rabbit lgG
antibody. After a further extensive wash, dishes were mounted in
0,1 M Tris (pH 7.4) - 50% glycerol (vol/vol) under glass coverslip
and examined with a Leitz microscope.
For electron microscopy, cells cultured in 35-mm diameter
collagen-coated Petri dishes were fixed for one hour at 4°C in
2.5% glutaraldehyde, 0.1 M cacodylate buffer (pH 7.4), post-fixed
for one hour at room temperature in 1% osmium tetroxide and
dehydrated with increasing concentration of ethanol before em-
bedding in LX-112 resin. Transversally cut sections were stained
with uranyl acetate and lead citrate, and studied with a Zeiss EM
109 electron microscope.
Experimental protocols
Confluent primary or immortalized peritoneal mesothelial cells
were incubated in serum-free medium for 24 hours before testing
the effects of hyperosmolality or TGF/31. In some experiments, 25
to 30% confluent cultures were also used and pre-incubated in
serum-free medium.
For cultures in hyperosmolar conditions, cells were incubated at
37°C for 60 minutes to 96 hours in serum-free DMEM supple-
mented or not with D-glucose, mannitol, sodium chloride, or
glycerol. These osmolytes increased medium osmolality from 320
mosm/kg (normal osmolality) to 500 mOsm/kg. Osmolalities were
measured by the freezing point depression method with a micro-
osmometer. Conditioned media were collected at the end of the
incubation time when it did not exceed 24 hours. For longer
exposures to hyperosmolality, media were harvested every 24
hours and replaced with fresh medium to allow sequential studies.
To assess the effect of TGF/31, confluent and non-confluent
cultures were incubated for 48 hours in serum-free medium
supplemented or not with 0.1 to 10 ng/ml TGFJ3I.
Harvested samples were immediately centrifuged at 700 g for
five minutes at 4°C to discard non adherent cells and stored at
—40°C until use. After two washes in normo-osmotic serum-free
medium, cells were lysed in 0.1 M NaOH for protein quantitation.
Cell protein content was assessed using a BCA protein assay®
(Pierce, Rockford, IL, USA) according to manufacturer specifi-
cations with BSA in 0.1 M NaOH as standard. Cell viability was
assessed by trypan blue exclusion and was more than 85% in all
experiments.
The effects of experimental conditions were assessed in at least
three independent experiments.
Substrate gel electrophoresis (zymography)
Cell-associated and secreted gelatinases were characterized by
zymography. Samples were applied without reduction on 7%
polyacrylamide gels containing I mg/mI gelatin, or when indi-
cated, 1 mg/mI type IV collagen. After electrophoresis, gels were
washed for 45 minutes in 2.5% Triton X-l00 to remove SDS,
incubated in substrate buffer [50 mM Tris, pH 7.5, 5 mvi CaC12, 1
niM ZnCl2 0.01% azide (wt/vol)] for 24 hours at 37°C, stained in
0.5% Coomassie Brilliant Blue (prepared in 30% ethanol, 10%
acetic acid, 1% formaldehyde) for 30 minutes at room tempera-
ture and destained three times for 15 minutes in the same buffer
devoid of Coomassie blue but enriched in formaldehyde to 5%.
The presence of metalloproteinases was indicated by unstained
proteolytic zones of the substrate. Both active and inactive
proenzymatic forms are revealed by this technique because expo-
sure of proenzyme to SDS during gel separation procedures leads
to activation without proteolytic cleavage [23].
In some experiments, the active forms of the gelatinases were
induced before zymographic analysis by incubating the samples
for three hours at 37°C with 1 mst p-aminophenyl mercuric
acetate (APMA).
Sensitivity of gelatinases to proteinase inhibitors was assessed
by adding inhibitors of thiol proteinases (leupeptin, 1 mM), serine
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proteinases (PMSF, 1 mu), aspartic acid proteinases (pepstatin, 1
mM), or metalloproteinases (EDTA, 10 mM; 1,10-phenanthroline,
1 mM) to the substrate buffer. In addition, because metallopro-
teinases require calcium ions for their activity, the ability of these
enzymes to create zones of lysis was tested when calcium chloride
was replaced by another divalent cation as Mg2 or Mn2 (5 mM)
in the substrate buffer.
All zymograms presented in Figures are representative of at
least three independent experiments performed in triplicate cul-
tures. Samples were normalized to cellular protein content. The
volume of conditioned medium loaded in each lane corresponded
to I to 5 g of cellular protein. Same results were obtained when
samples were normalized to cell number. Gelatinase activities
were quantitated by scanning the zymograms with a computing
densitometer (The Imager; Appligen, Illkirch, France). A linear
relationship was established between enzyme concentration and
the lytic band intensity [14].
Western blot analysis
Conditioned media were concentrated 30 to 40 times by
centrifugation using Amicon columns with a 10 kDa cut-off.
Samples of concentrated media normalized to cellular protein
content were loaded on 7% or 12% polyacrylamide gels with 3%
stacking gel, fractionated by SDS-PAGE under nonreducing
conditions, then electro-transferred onto nitrocellulose for two
hours at a constant current of 190 mA with a Bio-Rad Minipro-
tean II system.
The nitrocellulose membranes were saturated for one hour at
37°C with 10% fat-free dry milk in PBS (pH 7.4) containing 0.05%
Tween 20 and 1 mvt Levamisole. They were then incubated
overnight at 4°C with anti-human MMP2, anti-human MMP9,
anti-human TIMP-1, anti-human TIMP-2 or anti-human PAl-i
monoclonal antibodies (1 jig/mi) or with an irrelevant monoclonal
antibody (MOPC21) as a negative control. All antibodies were
diluted in 50 mivi Tris, 150 mi NaC1, Tween 20 0.05% (vol/vol),
pH 8. After extensive wash, membranes were incubated for two
hours at room temperature with a polyclonal goat anti-mouse Ig
antibody conjugated to alkaline phosphatase. They were then
washed, and binding of the second antibody was revealed with the
nitro blue tetrazolium/5-bromo-4-chioro-3-indolyl-phosphate
complex in 100 mM Tris, 100 mvi NaCl, 5 mivi MgC12 (pH 9.5). The
reaction was stopped by incubation in 20 mivi Tris, 5 mM EDTA,
pH 8.0.
Materials
All monoclonal antibodies were from mouse. Anti-human
MMP2, anti-human MMP9, anti-human T1MP-l, and anti-human
TIMP-2 monoclonal antibodies were obtained from Oncogene
Science (Cambridge, MA, USA). Anti-type-i plasminogen activa-
tor inhibitor (PAl-I) monoclonal antibody was from Biopool
(UmeA, Sweden). Anti-vimentin and anti-cytokeratin-18 mono-
clonal antibodies were from Amersham Corp. (Arlington Heights,
IL, USA). Anti-CD3I and anti-vWf monoclonal antibodies were
obtained from Dakopatt (Denmark). Anti-SV4O large-T Ag
monoclonal antibody (Pab416) was provided by Dr. C. Caron de
Fromentel (IRSC, Villejuif, France). Polyclonal rabbit antibodies
specific for type Ill collagen and type IV collagen, respectively,
were purchased from Institut Pasteur (Lyon, France). FITC-
conjugated goat anti-mouse and anti-rabbit lgG antibodies were
obtained from Biosys (Compiegne, France). G418 was from
Calbiochem (Meudon, France), and polybrene from Aldrich
Chemical Co. (Saint Quentin Fallavier, France). The micro-
osmometer 3M0 plus was from Advanced Instruments (Needham
Heights, MA, USA). Centricon 10 concentrators were obtained
from Amicon Inc. (Beverly, MA, USA). Human transforming
growth factor f31 (TGFj31) was purchased from Genzyme (Cam-
bridge, MA, USA).
Statistics
Results of semiquantitative densitometric analysis of relative
gelatinase activities were expressed as means SCM of five
experiments. Differences between means were evaluated with
Student's t-test. P < 0.05 was considered statistically significant.
Results
Characterization of primaiy cultures of human peritoneal
mesothelial cells
Confluent cells were polygonal and formed a regular monolayer
(Fig. IB). They expressed both cytokeratin (Fig. 1D) and vimentin
(Fig. iF). Cells failed to react with the endothelial markers vWf
and CD3I (not shown). They produced and excreted type IV
collagen (Fig. 1H) as well as type III collagen (not shown).
By electron microscopy, primary cultured mesothelial cells were
polarized with apical microvilli (Fig. 2A) and tight junctions (Fig.
2B, arrow). They did not contain any Weibel-Palade body.
Establishment and characterization of a human peritoneal
mesothelial cell line (HMrSV5)
A fully characterized primary culture of human peritoneal
mesothelial cells was infected with a large-T Ag encoding retro-
viral vector. Ten slowly growing mesothelial clones were expanded
for further characterization. Four of them have been extensively
studied and one, referred to as HMrSV5, was used throughout
this study. All HMrSV5 cells exhibited a specific nuclear staining
with anti-S V40 large-T Ag antibody (Fig. IA, insert).
Confluent HMrSVS cells had the same morphology as the
parental primary cultured cells (Fig. IA). They also displayed the
same phenotypic markers with co-expression of cytokeratin (Fig.
1C) and vimentin (Fig. 1E), production and excretion of type IV
collagen (Fig. 1G) and type III collagen, while they failed to
express endothelial markers, Like primary cultures, they produced
PAI-i/mesosecrin, a characteristic marker of mesothelial cells [24,
25] as shown by Western blot (Fig. 3G).
At the ultrastructural level, HMrSV5 cells were polarized with
apical microvilli (Fig. 2C) and tight junctions sealing the upper
lateral domain of contiguous cells (Fig. 2D, arrows). They exhib-
ited a well-developed endoplasmic reticulum (Fig. 2D), desnio-
somes (Fig. 2D, open arrow) and contained lamellar bodies (Fig.
2E), suggesting the synthesis of surfactant as previously described
in human mesothelial cells in vivo [26].
Characterization of gelatinases and TIMPs produced by HMrSV5
Zymograms of conditioned media revealed two major lytic
zones at 94 kDa and 68 kDa with two additional lytic bands at 64
kDa and 62 kDa (Fig. 3A). After incubation of conditioned media
with APMA, a substantial change in the gelatinolytic profile was
observed (Fig. 3B). The 94 kDa band decreased while an addi-
tional band of lysis appeared at 88 kDa corresponding to the
active form of the 94 kDa gelatinase. Similarly, the 68 kDa band
decreased and was partly converted into a 64 kDa band.
5c3A
Fig. 1. Phase contrast microscopy and immunofluorescence study of primaiy cultured mesothelial cells (B, I), F, H) and HMrSV5 cell line (A, C, E, G). Normal
and immortalized human peritoneal mesothelial cells were grown in 35-mm diameter type I collagen-coated Petri dishes. For immunofluorescence,
subconfluent cell cultures were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X 100, before incubation with mouse anti-cytokeratin
18 (C, D), anti-vimentin (E, F), anti-S V40 large-T antigen (A-insert) monoclonal antibodies or rabbit anti-type IV collagen polyclonal antibody (G, H). Binding
of the first antibody was revealed with a species-specific FITC-labeled second antibody. Immortalized cells (A) had the same morphology as the parental cells
in primary culture (B). All I-TMrSV5 cells expressed SV4O large-T antigen in nuclei (A-insert). Co-expression of cytokeratin 18 (C, D) and vimentin (E, F) was
observed on the same culture. Note linear extracellular deposits of type TV collagen in both cell populations (G, H). Controls including irrelevant
isotype-nsatched monoclonal or irrelevant polyelonal antibodies were negative (not shown). Magnifications: A and B, X62.5; A-insert, X312.5; C-H, x625.
SV4O
Rougier et al: Regulation of gelatinases in mesothelial cells 341
Fig. 2. Transmission electron micrographs of
primaly cultured (A, B) and immortalized (C—E)
mesothelial cells. Confluent cells grown in 35-
mm diameter Petri dishes were fixed in 2.5%
glutaraldehyde and post-fixed with osmium
tetroxide. After ethanol dehydration and
embedding in LX-112 resin, thin sections were
stained with uranyl acetate and lead citrate
before observation. Both primary cultures and
HMrSV5 cells were polarized with apical
microvilli (A, C), lateral tight junctions (B and
D, arrows) and desmosomes (D, open arrow).
HMrSV5 cells contained lamellar bodies
consistent with the production of surfactant-like
material (F). Magnifications: A and D, x7,000;
B and E, X20,000; C, x3,000.
Inhibitors of aspartic-acid proteinases (pepstatin A), serine
proteinases (PMSF) and thiol proteinases (leupeptin) did not
modify gelatinase activities (not shown). En contrast, specific
inhibitors of metalloproteinases, that is, 1,i0-phenarithroline (Fig.
3C) and EDTA (not shown) completely abolished the ability of
enzymes to degrade gelatin. Finally, no lytic band appeared when
calcium ions were replaced by Mg2 or Mn2 in the substrate
buffer (not shown).
Further identification of metalloproteinascs was achieved by
type IV collagen substrate gel electrophoresis and by immuno-
blotting. Type IV collagen zymogranis showed a lytic pattern
comparable to gelatin zyrnograms (Fig. 3D) with a lytic band at 94
kDa arid a doublet at 68 kDa and 64 kDa. Although samples were
normalized to cell protein content, lytic bands were weaker than
in gelatin gels. Western blotting analysis of whole concentrated
conditioned media with specific anti-MMP2 and anti-MMP9
monoclonal antibodies revealed a single band with an apparent
molecular weight of 68 kDa (Fig. 3E) and 94 kDa (Fig. 3F),
respectively.
No additional lytic band was seen around 55 kDa, the expected
molecular weight for stromelysin, in gelatin (Fig. 3A), type IV
collagen (Fig. 3D) or casein substrate gels (not shown).
Specific inhibitors of MMP9 and MMP2, that is, TIMP1 (Fig.
31-1) and TIMP2 (Fig. 31), were detected at the expected apparent
molecular weights of 28 and 21 kDa, respectively, by Western
blotting of concentrated conditioned media.
Modulation of gelatinase activity and protein and of TIMPJ by
hyperosmolality in HMrSV5 cell cultures
At the highest osmolality tested (500 mOsm/kg), MMP9 activity
normalized per cell protein content was markedly reduced after a
72-hour incubation with glucose while MMP2 activity was mini-
mally affected (Fig. 4A). To rule out a specific effect of glucose
irrespective of osmolality, other osmolytes were tested. Similar
inhibition of MMP9 activity was achieved with sodium chloride
(Fig. 4 A, D) and mannitol (not shown) but not with glycerol (Fig.
4 A, D), a permeant osmolyte, after 48 hours (Fig. 4D), 72 hours
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Fig. 3. Substrate gel electrophoresis and immunohiot analysis of gelatinases, PAl-I and TIMPs secreted by HMrSV5 cells. Aliquots (20 jsl) of 24-hour
serum-free conditioned media from confluent culture of HMrSV5 were analyzed by zymography in gelatin (A—C) or type IV collagen gels (D) as
indicated in the Methods section. Gelatinase activity was indicated as unstained lytic zones of the substrate. Note the constitutive expression of 68 kDa
and 94 kDa enzymes degrading both gelatin (A) and type IV collagen (D). Upon p-amino-phenyl mercuric acetate treatment both enzymes were
converted to lower molecular weight activated forms of 88 kDa and 64 kDa, respectively (B), whereas I, lO-phenanthroline abolished the activity of the
two proteases (C). Gelatin gels were purposely overloaded to demonstrate minor hands corresponding to constitutive secretion of activated gelatinases
(at 64 kDa and 62 kDa, A). For Western blot analysis, concentrated (X30 to 40) conditioned media were first submitted to eleetrophoresis under
nonreducing conditions in 7% (E—G) or 12% (H, I) polyacrylamide gels, then transferred onto nitrocellulose. Antigen identification was performed with
specific monoclonal antiodies to MMP2 (F.), MMP9 (F), PAT-i (G), TIMPI (H) and TIMP2 (I). Anti-MMP2 and anti-MMP9 antibodies revealed a
single band with apparent molecular weights of 68 kDa (E) and 94 kDa (F) corresponding to pro-enzymatic forms of the two metalloproteases.
Anti-TIMP1 and anti-TIMP2 antibodies recognized a single antigen at 28 kDa (TI) and 21 kDa (T), respectively, that is, at the expected molecular weight
for these two inhibitors. Immunoblotting also showed the presence of PAI-1/mesosecrin (G). Controls using isotype-matehed irrelevant monoclonal
antibodies were negative (not shown).
(Fig. 4A) or 96 hours (Fig. 4D). MMP9 inhibition was associated gelatinases as HMrSV5 cells (Fig. 4C). Second, hyperosmolality
with a dramatic decrease of MMP9 antigen as shown by Western had the same inhibitory effect on MMP9 as in HMrSV5 cells while
blotting (Fig. 4B), while TIMP1 antigen was not affected (Fig. MMP2 was modestly affected (Fig. 4C). This effect was observed
4B). with glucose and sodium chloride (Fig. 4C) but not with glycerol
To confirm the relevance of the HMrSV5 model, primary (not shown).
cultures from 18 different donors were studied in parallel. First, The osmolality effect was further analyzed as a function of
primary cultures consistently produced and excreted the same osmolyte concentration and time. As shown in Figure 5A and C,
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Fig. 4. Effects of hyperosmo/ic medium on MMP2, MMP9 and TIMPI secreted by IIMrSV5 cells (A, B, D) and by primmy cultured mesothelial celLs (C).
Confluent HMrSV5 cell cultures were treated for 72 hours with serum-free medium (320 mOsm/kg) supplemented or not with 180 mOsm/kg of glucose
(M+Glu), sodium chloride (M±NaCI), or glycerol ((fly) (A—C). Samples of conditioned media normalized to cell protein content were analyzed by
gelatin gel electrophoresis (A, C) and by Western blotting (B) after concentration (x30 to 40). Arrows indicate the position of MMP2 and MMPO.
Glucose and sodium chloride, hut not glycerol, suppressed the lytie band due to MMP9 without altering that of MMP2 in both cell populations (A, C).
MMP9 antigen was markedly reduced at 500 mOsm/kg of glucose while TIMPI antigen was not affected in conditioned media from HMrSV5 cells (B).
The unstained bands of lysis on the gelatin gels were quantified by densitometric scanning. Relative MMP9 activity after 48 (•) and 96 ([1) hours of
exposure to hyperosmotic medium was expressed as the percentage (mean suM) of the control value at normal osmolality (320 mOsm/kg) (D). *p < 0.05.
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Medium Medium÷glucose
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Osmolality 320 350 385 430 500
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Time
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Fig. 5. Osmolality- (A, C) and time-dependent (B, D) effects of hyperosmotic medium on MMP2 (LI) and MMP9 () secreted by HMrSV5 cells. Confluent
HMrSV5 cell cultures were incubated for 72 hours with serum-free medium supplemented or not with glucose (30 to 180 mOsmlkg) to reach final
osmolalities in the same range as in peritoneal dialysis fluids (350 to 500 mOsm/kg) (A, C). They were also incubated for 24 to 96 hours in control
medium supplemented or not with 180 mOsm/kg of glucose (B, D). Samples of conditioned media normalized to cell protein content were analyzed
by gelatin gel electrophoresis (A, B). Arrows indicate the position of MMP2 and MMP9. The unstained bands of lysis were quantified by densitometry
scanning (C, D). Relative gelatinase activity was expressed as the percentage (mean SEM) of the control value at normal osmolality (320 mOsm/kg)
(D). *p < 0.05. Osmolytes decreased the MMP9 lytic hand in a concentration-dependent manner, whereas MMP2 was only slightly reduced (A, C). Note
the early decrease of the MMP9 lytic hand after a 24-hour incubation with the osmolyte (B, D).
MMP9 activity was inhibited in a osmolality-dependent manner.
A significant effect was already observed at 385 mOsmlkg (Fig.
5C). The effect of osmolality was also time-dependent (Fig. 5
B,D). It was already significant at 24 hours and was maximal from
48 hours (Fig. 5D). MMP2 was not significantly decreased at any
osmolality up to 500 mOsm/kg (Fig. SC) and at any time (Fig. SI)).
Modulation of MMP9 activity and protein by TGFf1
The effects of TGFf3I on gelatinases were analyzed in confluent
and exponential (25% confluence) cultures of HMrSV5 and of
primary peritoncal mesothelial cells. In confluent cultures of
either cell population, TGFI31 did not modify MMP2 and MMP9
activities assessed by zyrnography (not shown). In contrast, in
nonconfluent HMrSV5 cell cultures, TGFf3I increased MMP9
lylic hand in a concentration-dependent manner, the maximal
effect being achieved at 5 nglml (Fig. 6). At this concentration,
MMP9 protein analyzed by Western blot was also increased in
whole concentrated conditioned media whereas MMP2 was not
affected (Fig. 6). Similar results were observed by zymography in
primary cultures of peritoneal mesothelial cells (Fig. 7). MMP9
activity also peaked at 5 ng/ml TGFf31.
Because TGF1 and hyperosmolality had divergent effects on
MMP9 activity and expression, confluent lIMrSV5 cells were
incubated in hyperosmotic medium supplemented (Fig. SC) or
not (Fig. 8B) with TGFf3I (5 nglml). Under these conditions, it
was possible to unmask a clear effect of TGFj31 that restored
MMP9 activity in cells exposed to hyperosmolar medium (Fig. SC
vs. SB).
Discussion
Filtration failure frequently limits in time the use of CAPD in
patients with end-stage renal failure. This complication is com-
monly associated with a thickening of the basement membrane
produced by peritoneal mesothelial cells and with submesothelial
peritoneal fibrosis. There is little information on the pathophysi-
ology of peritoneal fibrosis except for the well-established toxicity
500
24 48 72 96
C D
120
>'
: 100
0(5
oi5 80(I)'-5cz
. 0c)40
20I
0
>,
>
0(5
. 0
—0
—wo
F
120
10
80
60
40
20
0320 350 385 430 500
Osmolality, mOsm/kg
24 48 72 96
Time, hours
II
V
Rougier et a!: Regulation of gelatinases in mesothelial cells 345
MMP9 —
MMP2 —
M
TGF31 (ng/ml)
0.1 0.5 1 5 10
M TGFII1
(5 ng/ml)
M TGF31
(5 nglml)
Zymography Western blot
Fig. 6. Effects of TGFJ3I on MMP2 and MMP9 activity and protein in conditioned media of nonconfluent HMrSV5 cells. HMrSV5 cells were grown to 25%
confluence in complete medium. They were then incubated for 48 hours with 0.1 to 10 ng/ml TGFI3I in serum-free medium. Samples of conditioned
media normalized to cell protein content were analyzed by gelatin gel electrophoresis and after concentration by Western blotting with anti-MMP2 or
anti-MMP9 monoclonal antibodies. TGFJII increased MMP9 lytic band in a concentration-dependent manner with a maximum effect at 5 nglml. At the
same concentration, it also increased MMP9 Ag whereas MMP2 Ag was unchanged.
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Fig. 7. Effects of TGF/31 on MMP2 and MMP9
in conditioned media from nonconfluent primaly
cultures of mesothelial cells. Mesothelial cells
obtained by enzymatic digestion of omentum
pieces were grown to 25% confluence in
collagen-coated dishes. Cultures were treated
according to the same protocol as in Figure 6.
Samples of conditioned media normalized to
cell protein content were analyzed by gelatin
gel electrophoresis. TGF1 increased MMP9
lytic band in a concentration-dependent manner
with a peak at 5 ng/ml as in HMrSV5 cells.
MMP2 was not modified.
of dialysates for mesothelial cells [16] and the possible enhancing
role of infections [11. In this study, we focused on the matrix
metalloproteinase production by peritoneal mesothelial cells and
its regulation by hyperosmolality and TGFp-1.
For this purpose, we generated a well-differentiated human
peritoneal mesothelial cell line (HMrSV5) derived by transduc-
tion of a primary culture with a retroviral vector encoding SV4O
large-T Ag. To overcome cell "crisis" that occurred at passage 12,
HMrSV5 was maintained at a high cell density by frequent
subcultures as previously suggested [27]. HMrSV5 cell line be-
came established after the 20th passage with an apparently
unlimited proliferative potential. It has been continuously cul-
tured for two years, and still exhibits major features of mesothelial
cells and the same gelatinolytic profile. In contrast, mesothelial
cells in primary culture had a usual lifespan of 30 days correspond-
ing to 10 to 12 population doublings before senescence [18, 27,
28].
The mesothelial lineage of HMrSV5 was established by com-
parison with primary cultured mesothelial cells from different
donors according to morphological, immunocytochemical and
biochemical criteria [18, 29]. Both populations co-expressed cyto-
keratin and vimentin, a characteristic feature of mesothelial cells
[29]. HMrSVS cells also expressed PAI-1/mesosecrin which is
characteristic of cells from mesodermal origin [24, 251. They failed
to react with the endothelial markers vWf and CD3I and did not
contain Weibel-Paladc body on electron microscopical examina-
tion. The presence in HMrSV5 cells of lamellar bodies suggestive
of the synthesis of surfactant was the most specific ultrastructural
feature [26]. HMrSV5 also synthesized various extracellular ma-
trix components including type 111 collagen and type IV collagen
as did normal mesothehal cells [2, 3, 18].
HMrSV5 produced two matrix metalloproteinases: MMP2 and
MMP9. These type IV collagenases are able to degrade the
basement membrane collagen on which penitoneal mesothelial
cells lay. They were not induced by the cell trarisfection process
since they were also found in primary cultures and in LP-9 human
peritoneal mesothelial cells [7] derived from ascites fluid of a
patient with ovarian carcinoma [301. This suggests constitutive
I I MMP2
346 Rougier et al: Regulation of gelatinases in mesothelial cells
A B C
Fig. 8. TGFJ3J reverses the effects of hyperosmolalily on MMP9 in HMrSV5
cells. After a 24-hour serum deprivation, confluent HMrSV5 cell cultures
were incubated for 48 hours in serum-free normo-osmotic medium (320
mOsm/kg, A) or in hyperosmotic medium (500 mOsm/kg, B and C)
supplemented (C) or not (A, B) with 5 nglml TGFI31. Samples of
conditioned media normalized to cell protein content were analyzed by
gelatin gel electrophoresis. In cells exposed to hyperosmotic medium,
TGF1 could restore MMP9 activity (C vs. B). MMP2 activity was
marginally affected.
excretion of MMP2 and MMP9 by peritoneal mesothelial cells in
vivo.
Because of their superficial localization along the peritoneal
cavity, mesothelial cells are repeatedly exposed to dialysates with
high osmolalities due to glucose supplementation. We showed
that hyperosmolality markedly decreased MMP9 in a concentra-
tion- and time-dependent manner. This effect was observed at
osmolalities in the range of those of commercial dialysis fluids.
The effect of osmolality was not specific of glucose but was
independent of the tested osmolyte, provided it be osmotically
active. Indeed, glycerol, which does not induce a sustained cell
volume reduction [31], did not modify MMP9 activity. Thus, our
observations cannot be compared to those made in other cell
models, including mesangial [32, 33] and renal tubular [34] cells,
in which a glucose effect on extracellular matrix remodeling was
documented at normal osmolality. In these models, high glucose
concentrations specifically decreased metalloproteinase activity
through an increased production of TGFI3 [32,
Because MMP activities are not only controlled by the amount
of enzyme, but also by their inhibitors, we studied the effect of
hyperosmolality on TIMP1, the MMP9 specific inhibitor. TIMP1
protein was not decreased by hyperosmolality. 'l'herefore, the
gelatinolytic activity due to MMP9 is most likely decreased in
hyperosmolar conditions, which may account for an enhancing
effect of hyperosmolar dialysates on type IV collagen accumula-
tion. It might be argued that because MMP2, the main gelatinase
produced by mesothelial cells, was not affected, the overall type
IV collagenase activity should not be decreased by hyperosmola-
lity proportionally to the decrease of MMP9. However, MMP9 is
probably more important than MMP2 for the regulation of type
IV collagen turnover because it is a highly regulated enzyme, in
contrast with MMP2 which is mainly constitutive. In addition, the
spectrum of MMP9 activity may be broader towards collagen
types than that of MMP2 [361.
TGF is a fibrogenetic cytokine that increases matrix compo-
nents production, decreases proteinase activities, and increases
proteinase inhibitor synthesis [11, 37]. There are, however, excep-
tions to the TGF-mediated inhibition of proteases since in
several cell lines, TGFI3 displayed a stimulating effect on MMP2
[12, 131 or MMP9 [14]. We also observed a stimulating effect of
TGFI3I on MMP9 in human peritoneal mesothelial cells. First, in
exponentially growing cultures of normal mesothelial cells and of
the HMrSV5 cell line, TGF1 increased MMP9 activity and
protein. This effect suggests that the TGF1 that is most likely
released in the peritoneal cavity during infection may participate
to mesothelium healing, which involves degradation of accumu-
lated denatured collagens in addition to mesothelial regeneration
[1]. An excessive TGF/3 activity may nevertheless be fibrogenetic
since degradation of basement membrane type IV collagen may
favor its replacement by interstitial collagens. An accumulation of
interstitial collagens in the submesothelial tissue may in turn limit
the recruitment of mesothelial "stem" cells [1]. Second, although
TGF1 did not modify MMP9 activity and protein in confluent
mesothelial cell cultures, it restored MMP9 activity in cells
exposed to hyperosmolality, which again may favor degradation of
denuded basement membrane and possibly the accumulation of
interstitial collagens instead of type IV collagen. Because normal
mesothelial cells [38, 39] and the HMrSV5 cell line (Rougier,
personal communication) produce TGFI3, we suggest that TGFI3
may regulate MMP9 in an autocrine fashion.
In summary, we have established a well-differentiated human
peritoneal mesothelial cell line that exhibits the same matrix
degradative phenotype as the normal parental cells. Hypertonicity
decreases MMP9 without affecting TIMPI and thus may enhance
extracellular accumulation of type IV collagen. On the other
hand, TGFJ31 has a cell density-dependent stimulating effect on
MMP9 expression. Further in vitro studies using this relevant
model may help to define more biocompatible dialysates, and thus
limit the loss of ultrafiltration in patients treated by peritoneal
dialysis.
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